Hutch News
Results per Page:
Functionalizing the genome to find novel pancreatic cancer treatments
From the Kemp Lab, Human Biology Division
Diving into the dark kinome to identify synthetic lethal RAS therapeutic targets
From the Kemp Lab, Human Biology Division
Two pathways, one destination: promising drug combination to treat ovarian cancer
From the Kemp Lab, Human Biology Division
Personalized medicine for head and neck cancer
from the Mendez lab, Clinical Research Division, and Kemp lab, Human Biology Division
Functional genomics pinpoints unique tumor vulnerabilities
Technique pinpoints unique tumor vulnerabilities — even when they are not written in tumor DNA
Early phase clinical trial shows promise for advanced head and neck cancer
Nine out of 10 patients treated with the experimental therapy saw their tumors shrink
Data drives life sciences boom in Seattle
Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference
$7 million grants boost functional genomics team science
Dr. Chris Kemp’s 2 NCI awards will help support drug-target discovery and commercialization for personalized oncology
Dr. Goldie Lui receives funding from Ovarian Cancer Research Alliance
Celebrating faculty and staff achievements
To be an oncogene or a tumor suppressor? The answer lies in the dose of p27
From the Kemp lab, Human Biology Division
Good News: NCI awards Dr. Ruth Etzioni 5-year grant to fill gaps in cancer-recurrence data
Celebrating faculty and staff achievements
Finding ways to deliver on the promise of precision oncology
‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients
Team awarded $4.4 million from the National Cancer Institute for pioneering immunogenic cancer research
Harnessing new technologies of high-throughput screening and large-scale public data mining to find new immunotherapy targets
Team receives $4 million from national cancer institute to develop precision cancer treatments - Fred Hutchinson Cancer Research Center
Breakthrough research uses high-throughput screening to identify and target specific cancer genes in patients
Researchers closer to early lung cancer detection
Sam Hanash leads discovery of blood proteins associated with early development of lung cancer; findings hold promise of a blood test for screening, diagnosis
Systems biology may improve early detection of aggressive breast cancer
Chris Kemp and Sam Hanash’s study is the first to examine how blood protein levels change as cancer develops—long before the disease is clinically detectable
Using a 'systems biology' approach to look under the hood of an aggressive form of breast cancer
Study is the first to examine how blood protein levels change as cancer develops – long before the disease is clinically detectable
Improving biomarker development to improve patient outcomes
Amanda Paulovich and colleagues find proof-of-concept study of biomarker development provides roadmap for similar approach in humans
The melding of diverse minds around proteomics initiative
Paulovich Lab harnesses specialists from a variety of fields for contributions to $104 million National Cancer Institute network
Generous gift for early detection
Paul G. Allen Family Foundation grants $5 million for biomarker research